Skip to content

Abstract A054: Comparative efficacy analysis of the polyisoprenylated cysteinyl amide inhibitor and sotorasib in lung cancer NCI-H23 mutant cell models

Oct 2026 · Cancer Epidemiology, Biomarkers & Prevention · 0 citations

Abstract

Lung Cancer remains the leading cause of cancer-related deaths worldwide, with African Americans experiencing the highest incidence and mortality rates compared to other ancestry-related groups in the United States. KRAS mutations account for approximately 30% of all cases. While KRASG12C inhibitor Sotorasib shows efficacy, its long-term benefit is limited by compensatory resistance mechanisms such as the overexpression of wild-type KRAS. In addition to resistance, other undrugged KRAS mutants create an urgent need for pan-KRAS therapies with activity across multiple KRAS-mutant subtypes. Polyisoprenylated Amide Cysteinyl Inhibitors (PCAIs) are mutant-agnostic agents that suppress the polyisoprenylation-dependent interactions of monomeric small G-proteins such as KRAS and RHO family GTPases, disrupting downstream signaling. PCAIs NSL-YHJ-2-27 inhibited the viability of NCI-H23 cells with KRASG12C and KRASG12A mutations with EC50 values of 3.0 and 3.2 µM, respectively, while Sotorasib exhibited EC50 values of 15 µM and 24 µM, respectively, against the same cells. At 3 µM, NSL-YHJ-2-27 significantly inhibited colony formation in KRASG12C and KRASG12A by 99 and 72%, respectively. As expected, Sotorasib significantly inhibited colony formation in KRASG12C by 70% but only 36% in KRASG12A cells. NSL-YHJ-2-27 at 5 µM significantly inhibited KRASG12C and KRASG12A cell migration by 64% and 53%, respectively. Sotorasib did not affect KRASG12A cell migration. Transcriptomic RNA sequencing after exposure to 3 µM NSL-YHJ-2-27 revealed the differential expression of genes involved in inflammatory responses, cytoskeletal organization, and apoptotic signaling. Prolonged treatment with 5 µM resulted in the loss of Sotorasib efficacy against KRASG12C cells and no inhibitory effect on KRASG12A proliferation. In contrast, 5 µM NSL-YHJ-2-27 maintained a robust antiproliferative activity, reducing cell counts by 4-fold in both KRASG12C and KRASG12A cells. Collectively, these findings support PCAIs as pan-KRAS therapeutic agents with the potential to overcome the limitations of mutation-specific KRAS drugs. Chase Lilly, Chunli Yan, Matthew Gladstone, Benjamin Ryder, Kyle Phillips, Jahnissi Odoom, Karla Gonzalez, Joshua Kofi Ablordeppey, Ite A. Offringa, Nazarius S. Lamango, Kweku Ofosu-Asante, Desmond Kwakye, Yong Huang. Comparative efficacy analysis of the polyisoprenylated cysteinyl amide inhibitor and sotorasib in lung cancer NCI-H23 mutant cell models [abstract]. In: Proceedings of the 19th AACR Conference on the Science of Cancer Health Disparities; 2026 Oct 18-21; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2026;35(10 Suppl):Abstract nr A054.

View source

Similar papers

#computer vision Review Open access May 2015

A survey study on major technical barriers affecting the decision to adopt cloud services

The comparison of adopter and non-adopter sample reveals three potential adoption inhibitor, security, data privacy, and portability, which underlines the importance of the technical and security perspectives for research investigating the adoption of technology.

Nattakarn Phaphoom, Xiaofeng Wang, S. Samuel et al. · 111 citations · ⚡8
#computer vision Open access Feb 2018

Lean Internal Startups for Software Product Innovation in Large Companies: Enablers and Inhibitors

This study investigates how Lean internal startup facilitates software product innovation in large companies and identifies its enablers and inhibitors, and shows the potential of the method-in-action framework to investigate the Lean startup approach in non-startup context.

Henry Edison, Nina M. Smørsgård, Xiaofeng Wang et al. · 78 citations · ⚡6
#computer vision Book Open access Jul 2015

Understanding the affect of developers: theoretical background and guidelines for psychoempirical software engineering

This paper highlights the challenges to conduct proper affect-related studies with psychology, provides a comprehensive literature review in affect theory, and proposes guidelines for conducting psychoempirical software engineering.

D. Graziotin, Xiaofeng Wang, P. Abrahamsson · 56 citations · ⚡4
#machine learning Open access May 2017

What Influences the Speed of Prototyping? An Empirical Investigation of Twenty Software Startups

This study conducts a multiple case study on twenty European software startups and proposes a prototype-centric learning model in early stage software startups, and identifies factors that occur as barriers but also facilitators for prototyping in earlystage software startups.

Anh Nguyen-Duc, Xiaofeng Wang, P. Abrahamsson · 44 citations · ⚡5
#protein folding Open access Sep 2026

Programmable design of functional proteins from natural language

Pinal, a 16-billion-parameter foundation model that produces protein candidates from natural-language functional descriptions, supports natural language as a high-level interface for candidate generation in protein design, enabling programmable exploration with reduced reliance on manually specified structural or seque...

Fengyuan Dai, Shiyang You, Yudian Zhu et al. · 31 citations · ⚡3

Related blog posts

Google DeepMind Blog Sep 30, 2026

Introducing SynthID Bio

Proof of concept for watermarking AI-generated proteins while preserving biological function.

MIT News · Artificial Intelligence Aug 27, 2026

Looking beyond natural sequences

A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.